Close

Forma Therapeutics Holdings (FMTX) Announces FT-4202 Receives Orphan Drug Designation in Europe for Treatment of Sickle Cell Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. HCP
7. BSX
8. PI
9. NOW
10. SNAP


Go back to Forma Therapeutics Holdings (FMTX) Announces FT-4202 Receives Orphan Drug Designation in Europe for Treatment of Sickle Cell Disease
(NASDAQ: FMTX) Delayed: 20.01 --0 (-0%)
Previous Close $20.01    52 Week High $ 
Open $20.01    52 Week Low $ 
Day High $20.01    P/E N/A 
Day Low $20.01    EPS $ 
Volume 58,798